Carney Conversations: Making advances in Alzheimer’s research from the bench to the bedside

Share on Social Media

The Carney Institute for Brain Science held a conversation focused on Alzheimer’s research at Brown University, featuring: – Stephen Salloway, Martin M. Zucker Professor of Psychiatry and Human Behavior at Brown, director of neurology and the Memory and Aging Program at Butler Hospital in Providence, RI – Ashley Webb, Richard and Edna Salomon Assistant Professor of Molecular Biology, Cell Biology and Biochemistry The event was moderated by Diane Lipscombe, Reliance Dhirubhai Ambani Director of the Carney Institute, and Christopher Moore, associate director of the Carney Institute. https://events.brown.edu/brain-scienc… November 24, 2020 Brown University

Latest News

Women In Bio (WIB) Announces Launch of 14th Chapter: WIB-Connecticut

Sea Island, GA, March 03, 2021 (GLOBE NEWSWIRE) -- Women In Bio (WIB), a national organization of professionals committed to promoting the careers, leadership and entrepreneurship of women in the life sciences, is excited to announce the launch of WIB-Connecticut, the...

Top pharma industry predictions for 2021

In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds. Perhaps more than most other industries, the landscape of pharma was radically altered by...

DRIVEN/RI-INBRE Ignition Fund FOA – DEADLINE January 11, 2021

Funding is sparse for commercial-focused biomedical projects due to their inherent risks. The DRIVEN Accelerator Hub, an NIH/NIGMS-funded consortium serving biomedical entrepreneurs in Northeast IDeA states (https://www.drivenacceleratorhub.com/), is pleased to offer...

Slater Technology Fund-backed company to be acquired by Novartis

Slater Technology Fund-backed company to be acquired by Novartis

PROVIDENCE – The Cambridge, Mass.-based company Cadent Therapeutics has entered into an agreement to be acquired by Novartis in a deal worth up to $770 million, Slater Technology Fund announced Friday. The company was formed through a merger with the Slater Technology...

Biotech Industry News